# NEUROONE MED TECHNOLOGIES CO COM

NEUROONE MED TECHNOLOGIES CO COM is a security (CUSIP 64130M308) tracked across SEC portfolio filings. 5 institutional managers reported $914K on Form 13F as of 2026-06-30.

## Summary

- Issuer: NEUROONE MED TECHNOLOGIES CO
- Class: COM
- CUSIP: 64130M308
- 13F holders: 5
- 13F value: $914K
- 13F period: 2026-06-30
- N-PORT fund positions: 0

## Top institutional holders (Form 13F)

| Manager | Location | Value | Shares |
| --- | --- | --- | --- |
| PERKINS CAPITAL MANAGEMENT INC | WAYZATA, MN | $744K | 244,656 |
| [ESSEX INVESTMENT MANAGEMENT CO LLC](https://search.stillhousedata.com/firm/109962) | BOSTON, MA | $132K | 43,578 |
| [Belpointe Asset Management LLC](https://search.stillhousedata.com/firm/143440) | RENO, NV | $38K | 12,500 |
| Cambridge Investment Research Advisors, Inc. | FAIRFIELD, IA | $87 | 28,499 |
| SBI Securities Co., Ltd. | TOKYO, M0 | $40 | 13 |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/64130M308.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.